Colgate-Palmolive Company (NYSE:CL) Shares Bought by Revisor Wealth Management LLC

Revisor Wealth Management LLC grew its holdings in Colgate-Palmolive Company (NYSE:CL) by 80.6% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,753 shares of the company’s stock after buying an additional 2,121 shares during the period. Revisor Wealth Management LLC’s holdings in Colgate-Palmolive were worth $445,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of CL. Westend Capital Management LLC grew its holdings in Colgate-Palmolive by 111.1% in the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock valued at $25,000 after buying an additional 140 shares in the last quarter. Vermillion Wealth Management Inc. purchased a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $31,000. Briaud Financial Planning Inc acquired a new stake in Colgate-Palmolive during the fourth quarter worth about $32,000. Wintrust Investments LLC purchased a new position in Colgate-Palmolive during the fourth quarter worth about $33,000. Finally, Bernard Wealth Management Corp. acquired a new position in Colgate-Palmolive in the 4th quarter valued at about $33,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Price Performance

Shares of CL opened at $92.36 on Thursday. The company has a market cap of $74.85 billion, a P/E ratio of 26.09, a PEG ratio of 4.89 and a beta of 0.37. Colgate-Palmolive Company has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96. The firm’s 50 day moving average price is $90.68 and its 200 day moving average price is $90.57.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.86 by $0.05. The business had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.92 billion. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The company’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.86 earnings per share. On average, research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive declared that its Board of Directors has approved a share buyback program on Thursday, March 20th that authorizes the company to buyback $5.00 billion in shares. This buyback authorization authorizes the company to purchase up to 6.8% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s board believes its stock is undervalued.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be given a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date is Friday, July 18th. Colgate-Palmolive’s dividend payout ratio is currently 58.76%.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. Piper Sandler reduced their price target on shares of Colgate-Palmolive from $108.00 to $107.00 and set an “overweight” rating on the stock in a research report on Monday, March 31st. Wells Fargo & Company lifted their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the company an “underweight” rating in a research report on Wednesday, April 2nd. Wall Street Zen lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Wednesday, May 7th. Barclays cut their price objective on Colgate-Palmolive from $89.00 to $86.00 and set an “equal weight” rating for the company in a research report on Friday, April 11th. Finally, Citigroup upped their target price on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the company a “buy” rating in a research report on Monday, April 28th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $101.69.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.